HEALTH

FDA approves Confidant mobile phone system for OTC sales

BY Drew Buono

RESEARCH TRIANGLE PARK, N.C. The Food and Drug Administration has given Confidant market clearance for the over-the-counter sale of its chronic disease management product. Confidant is a manufacturer of mobile communication solutions for chronic disease management.

In May 2005, Confidant became the first company to receive clearance from the FDA for a mobile phone-based system to communicate with multiple home medical devices. This was followed by the October 2006 clearance, which included significant user interface improvements and the ability to work with a broader group of home medical devices.

Initially, the focus was on home diabetes management, with the system being capable of collecting data from a range of glucose meters, weight scales and blood pressure devices. With the OTC product, users can collect data from the same full range of off-the-shelf devices supported by the company’s prescription product. Objective and motivational feedback is returned directly to the user’s cell phone within seconds and automatic reminders help the user keep on track with routine monitoring.

Patient data can be accessed directly through the Confidant portal or by accessing Personal Health Record or Electronic Medical Record systems that are populated from the Confidant system.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Heinrich, Morfit named to AMO board of directors

BY Michael Johnsen

SANTA ANA, Calif. Advanced Medical Optics on Wednesday announced the election of Daniel Heinrich and Mason Morfit to its board of directors, increasing the company’s board to 10 members.

Since 2003, Heinrich, 51, has been senior vice president and chief financial officer of The Clorox Company. Morfit, 32, is a partner at San Francisco-based ValueAct Capital Partners, a private investment partnership with more than $6 billion in assets.

ValueAct Capital is AMO’s largest stockholder.

“Dan and Mason each bring distinct experiences that will broaden and enrich our board,” stated Jim Mazzo, AMO chairman and chief executive officer. “Dan’s extensive financial expertise and understanding of the global consumer market will be immensely valuable as we execute our complete refractive solution strategy. Mason brings the perspective of a major stockholder with demonstrated governance and capital markets expertise. We are pleased to welcome both gentlemen as new directors and look forward to their contributions.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

NBA’s Brandon Roy signs agreement with CytoSport

BY Michael Johnsen

BENICIA, Calif. CytoSport on Tuesday announced a multi-year spokesman agreement with the last season’s National Basketball Association Rookie of the Year Brandon Roy of the Portland Trail Blazers.

“We are excited to have Brandon join our family of sponsored athletes,” stated Greg Pickett, CytoSport president. “It’s been an exciting year here for us as we also signed Adrian Peterson of the Vikings this summer and have been working with Shaquille O’Neal since January. It will be great to work with Brandon early in his career, and we hope to have a long-standing relationship with him.”

Under the terms of the agreement, Roy will appear in print advertisements for CytoSport’s Muscle Milk and Cytomax products. Roy will also have a strong web presence on behalf of CytoSport.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?